Bristol Investment Fund, Ltd. 13D and 13G filings for GT Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-23 8:31 pm Purchase | 2024-05-23 | 13G | GT Biopharma, Inc. GTBP | Bristol Investment Fund, Ltd. | 190,000 8.800% | 179,162 (+1653.09%) | Filing |
| 2022-03-02 9:28 pm Sale | 2022-02-28 | 13G | GT Biopharma, Inc. GTBP | Bristol Investment Fund, Ltd. | 10,838 1.060% | -28,905 (-72.73%) | Filing |
| 2021-04-16 07:59 am Purchase | 2021-04-05 | 13G | GT Biopharma, Inc. GTBP | Bristol Investment Fund, Ltd. | 39,743 4.170% | 26,763 (+206.19%) | Filing |
| 2021-02-08 3:08 pm Unchanged | 2020-12-31 | 13G | GT Biopharma, Inc. GTBP | Bristol Investment Fund, Ltd. | 12,980 7.910% | 0 (Unchanged) | Filing |
| 2020-06-10 08:08 am Purchase | 2020-06-08 | 13G | GT Biopharma, Inc. GTBP | Bristol Investment Fund, Ltd. | 12,980 9.360% | 5,933 (+84.18%) | Filing |
| 2020-05-18 4:06 pm Purchase | 2020-05-15 | 13G | GT Biopharma, Inc. GTBP | Bristol Investment Fund, Ltd. | 7,047 5.080% | 1,132 (+19.14%) | Filing |